| Description | General information | Package insert |
Remarks |
| American Diagnostica ActiClot dPT |
Method: Clotting (dPT), screening and confirmation Sensitivity: Insensitive to deficiencies of Factor XII |
||
| American Diagnostica LA Complete | Method: Clotting (DRVVT and dPT), screening and confirmation | ||
| American Diagnostica DVV confirm | Method: Clotting (DRVVT), confirmation | ||
| American Diagnostica DVV test |
Method: Clotting (DRVVT) Sensitivity: Insensitive to deficiencies of Factor VIII, IX, XI and XII or their respective inhibitors |
||
| BioData Lupus Anticoagulant Confirmation Reagent |
Method: Clotting (PNP), confirmation |
||
| BioData Corporation Platelet extract reagent |
Method: Clotting (PNP) |
||
| DG-DRVVT |
Method: Clotting (DRVVT), screening |
||
| DG-DRVVT Confirm |
Method: Clotting (DRVVT), confirmation |
||
| Diagen BeA |
Method: Clotting (APTT) |
||
| Diagen KPS |
Method: Clotting (APTT/KCT) |
||
| Diagen Micronised Silica APTT |
Method: Clotting (APTT) Sensitivity: High sensitive to heparin and lupus |
||
| Diagen RVV |
Method: Clotting (DRVVT) |
||
| Diagnostic Lupotek KCT reagent |
Method: Clotting (KCT) |
||
| Dialab APTT-S |
Method: Clotting (APTT) |
||
| Haematex dRVT-LS | Method: Clotting (DRVVT), screening | ||
| Haematex dRVT-LR | Method: Clotting (DRVVT), confirmation | ||
| Haematex SACT Reagent | Method: Clotting (KCT) | ||
| Helena BioSciences DRVVT confirm |
Method: Clotting (DRVVT), confirmation Sensitivity: Insensitive to heparin <1 IU/mL |
||
| Helena BioSciences DRVVT screen |
Method: Clotting (DRVVT), screening Sensitivity: Insensitive to heparin <1 IU/mL |
||
| Hyphen BioMed Cephen | Hyphen BioMed Cephen |  |
Method: Clotting (APTT) |
| Hyphen BioMed Cephen LS | Hyphen BioMed Cephen LS | |
Method: Clotting (APTT) |
| I.L. APTT SP | I.L. APTT SP | |
Method: Clotting (APTT) |
| I.L. HemosIL RecombiPlasTin (2nd generation) | I.L. HemosIL RecombiPlasTin (2nd generation) | |
Method: Clotting (PT)
Sensitivity: High sensitive to deficiencies of Factor X, VII, V and II, Insensitive to therapeutic levels of heparin |
| I.L. HemosIL SynthAFax | I.L. HemosIL SynthAFax | |
Method: Clotting (APTT)
Sensitivity: Sensitive to factor VIII, IX, heparin and lupus |
| I.L. HemosIL SynthASil | I.L. HemosIL SynthASil | |
Method: Clotting (APTT)
Sensitivity: Sensitive to the contact phase activation, heparin and lupus |
| I.L. HemosIL dRVVT Screen | I.L. HemosIL dRVVT Screen | |
Method: Clotting (DRVVT), screening |
| I.L. HemosIL dRVVT Confirm | I.L. HemosIL dRVVT Confirm | |
Method: Clotting (DRVVT), confirmation |
| I.L. SCT confirm | I.L. SCT confirm | |
Method: Clotting (SCT), confirmation Sensitivity: insensitive to oral anticoagulant therapy |
| I.L. SCT screen | I.L. SCT screen | |
Method: Clotting (SCT), screening Sensitivity: Sensitive to lupus, insensitive to oral anticoagulant therapy |
| Kaogen Koalup Confirm |
Method: Clotting (DRVVT), confirmation Sensitivity: Insensitive to contact factor deficiencies, factor VIII inhibitors and heparin within therapeutic ranges |
||
| Kaogen Koalup Screen |
Method: Clotting (DRVVT), screening Sensitivity: Insensitive to contact factor deficiencies, Factor VIII inhibitors and heparin within therapeutic ranges |
||
| Kaogen KaoTime |
Method: Clotting (KCT), screening Sensitivity: Sensitive to platelet procoagulants |
||
| Life Diagnostic LA confirm |
Method: Clotting (DRVVT), confirmation |
||
| Life Diagnostic LA screen |
Method: Clotting (DRVVT), screening Sensitivity: Insensitive to contact factor deficiencies, factor VIII deficiencies and antibodies |
||
| Nycomed Thrombotest | Method: Clotting (TT)
Sensitivity: Sensitive to factor II, VII and X deficiencies and PIVKA factors |
||
| Nycomed Nycotest | Method: Clotting (PT)
Sensitivity: Sensitive to factor II, VII and X deficiencies, Insensitive to heparin in therapeutic doses |
||
| Precision Biologic LA check | Precision Biologic LA check | |
Method: Clotting (DRVVT), screening |
| Precision Biologic LA sure | Precision Biologic LA sure | |
Method: Clotting (DRVVT), confirmation |
| Precision Biologic Platelet Lysate | Precision Biologic Platelet Lysate | |
Method: Clotting (PNP) |
| R²Diagnostics Lupo Tek Correctin VL |
Method: Clotting (DRVVT), confirmation |
||
| R² Diagnostics Lupo Tek Detectin VL |
Method: Clotting (DRVVT), screening |
||
| R² Diagnostics LupoTek KCT | Method: Clotting (APTT), screening | ||
| Siemens Actin | Method: Clotting (APTT)
Sensitivity: Moderate sensitive to intrinsic factor deficiencies and lupus, Low sensitive to heparin |
||
| Siemens Actin FS | Method: Clotting (APTT)
Sensitivity: High sensitive to intrinsic factor deficiencies and heparin, Moderate sensitive to lupus |
||
| Siemens Actin FSL | Method: Clotting (APTT)
Sensitivity: Sensitive to lupus and intrinsic factor deficiencies, Moderate sensitive to heparin |
||
| Siemens Innovin | Method: Clotting (PT)
Sensitivity: Highly sensitive to extrinsic factor deficiences and oral anticoagulant therapy, Insensitive to theurapeutic levels of heparin |
||
| Siemens LA1 screen |
Method: Clotting (DRVVT), screening |
||
| Siemens LA2 confirmation |
Method: Clotting (DRVVT), confirmation |
||
| Siemens Pathromtin SL | Method: Clotting (APTT)
Sensitivity: Highly sensitive to lupus, factor deficiences and heparin |
||
| Siemens Thromboplastin C+ | Method: Clotting (PT) | ||
| Siemens Thromborel S | Method: Clotting (PT)
Sensitivity: High sensitive to prothrombin, VII and X |
||
| Stago Cephascreen |
Method: Clotting (APTT) |
||
| Stago CKPrest | Method: Clotting (APTT) | ||
| Stago DRVVT confirm |
Method: Clotting (DRVVT), confirmation Sensitivity: Insensitive to UFH, contact factor deficiencies, factor VIII and IX deficiences or inhibitors |
||
| Stago DRVVT screen |
Method: Clotting (DRVVT), screening Sensitivity: Insensitive to UFH, contact factor deficiencies, factor VIII and IX deficiences or inhibitors |
||
| Stago Kaolin | Method: Clotting (APTT) | ||
| Stago Neoplastin CI |
Method: Clotting (PT) Sensitivity: Insensitive to heparin |
||
| Stago Neoplastin CI+ |
Method: Clotting (PT) |
||
| Stago Neoplastin R |
Method: Clotting (PT) Sensitivity: Insensitive to heparin |
||
| Stago PTT | Method: Clotting (APTT) | ||
| Stago PTT Automate | Method: Clotting (APTT) | ||
| Stago PTT LA |
Method: Clotting (APTT), screening |
||
| Stago STA APTT |
Method: Clotting (APTT) |
||
| Stago Staclot LA |
Method: Clotting (DRVVT), confirmation |
||
| Tcoag TriniCLOT APTT-HS |
Method: Clotting (APTT) Sensitivity: Sensitive to lupus and heparin |
||
| Tcoag TriniCLOT APTT-S |
Method: Clotting (APTT) |
||
| Tcoag TriniCLOT Automated APTT |
Method: Clotting (APTT) Sensitivity: Sensitive to heparin, Insensitive to Factor VII or platelet deficiencies |
||
| Tcoag TriniCLOT Lupus Confirm |
Method: Clotting (DRVVT), confirmation |
||
| Tcoag TriniCLOT Lupus Screen |
Method: Clotting (DRVVT), screening |
||
| Tcoag TriniCLOT PT Excel | Method: Clotting (PT) | ||
| Tcoag TriniCLOT PT Excel S | Method: Clotting (PT) | ||
| Tcoag TriniCLOT PT HTF | Method: Clotting (PT) | ||
| Tcoag TriniCLOT Venom Time |
Method: Clotting (DRVVT), screening Sensitivity: Insensitive to heparin |
||
| Technoclone Lupus Anticoagulant Confirm | Technoclone Lupus Anticoagulant Confirm | |
Method: Clotting (DRVVT), confirmation Sensitivity: Insensitive to contact factor deficiencies, factor VIII inhibitor and anticoagulants within therapeutic ranges |
| Technoclone Lupus Anticoagulant Screen | Technoclone Lupus Anticoagulant Screen | |
Method: Clotting (DRVVT), screening Sensitivity: Insensitive to contact factor deficiencies, factor VIII inhibitor and anticoagulants within therapeutic ranges |
| Technoclone Lupus Anticoagulant Test | Technoclone Lupus Anticoagulant Test | |
Method: Clotting (APTT) |
| Vital Diagnostics Vitaclot | Method: Clotting (APTT) | ||
| Vital Diagnostics Vitaclot SACT | Method: Clotting (APTT) |
© Copyright - Ecat